The impact of hydroxychloroquine–azithromycin combination on Tpeak‐to‐end and Tpeak‐to‐end/QT ratio during a short treatment course

BACKGROUND: Since there was no proven treatment of coronavirus disease 2019 (COVID‐19), hydroxychloroquine–azithromycin (HCQ‐AZM) combination is being used in different countries as a treatment option. Many controversies exist related to the safety and effectiveness of this combination, and question...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakhshaliyev, Nijad, Özdemir, Ramazan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293593/
https://www.ncbi.nlm.nih.gov/pubmed/33956361
http://dx.doi.org/10.1111/anec.12846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293593/
https://www.ncbi.nlm.nih.gov/pubmed/33956361
http://dx.doi.org/10.1111/anec.12846

Ejemplares similares